Gastric Surgery Division, National Cancer Center Hospital East, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Gastric Surgery Division, National Cancer Center Hospital East, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Eur J Surg Oncol. 2019 Aug;45(8):1505-1510. doi: 10.1016/j.ejso.2019.03.030. Epub 2019 Mar 26.
Splenectomy for advanced gastric stump cancer (GSC) is performed in Japan, based on the concept that lymphatic flow toward the splenic hilum is dominant following initial gastrectomy. However, little has been reported on the therapeutic impact of complete splenic hilar dissection with splenectomy.
A total of 184 patients who underwent R0 total gastrectomy with or without splenectomy for GSC between 1998 and 2015 were included in this retrospective analysis. Patients were divided into subgroups: patients with tumors involving the greater curvature (Gre group) and tumors without greater curvature involvement (non-Gre group), and each group was further divided into those with and without splenectomy. The incidence of lymph node (LN) metastasis, index of the estimated benefit from LN dissection in each station, and survival curves were compared.
The incidence of No.10 LN metastasis was higher in the Gre group than in the non-Gre group (16.7% vs. 2.0%, P = 0.036). The index of No.10 LN dissection was higher in the Gre group than in the non-Gre group (6.3 vs. 0). However, there was no tendency that splenectomy was superior to spleen preservation for survival outcomes in either group, although selection bias certainly existed.
In advanced GSC, similar to primary advanced proximal gastric cancer, splenectomy can be omitted unless the tumor infiltrates the greater curvature. Complete splenic hilar dissection may be expected to be beneficial for some patients with tumors infiltrating the greater curvature.
日本施行针对进展期残胃癌(GSC)的脾切除术,基于初始胃切除术后,向脾门方向的淋巴流向占主导地位的理念。然而,对于完全脾门解剖联合脾切除术的治疗效果,相关报道较少。
本回顾性分析纳入了 1998 年至 2015 年间因 GSC 行 R0 全胃切除术且伴或不伴脾切除术的 184 例患者。患者分为两组:肿瘤累及胃大弯(Gre 组)和肿瘤不累及胃大弯(非-Gre 组),每组进一步分为伴脾切除术和不伴脾切除术两组。比较了各组的淋巴结(LN)转移发生率、各站 LN 清扫获益指数和生存曲线。
Gre 组的 No.10LN 转移发生率高于非-Gre 组(16.7% vs. 2.0%,P=0.036)。Gre 组的 No.10LN 清扫获益指数高于非-Gre 组(6.3 vs. 0)。然而,两组均无脾切除术优于保留脾脏的生存优势趋势,尽管确实存在选择偏倚。
在进展期 GSC 中,与原发性进展期近端胃癌相似,除非肿瘤累及胃大弯,否则可省略脾切除术。对于累及胃大弯的部分肿瘤,完全脾门解剖可能有益。